VantAI and TARA Biosystems Partner to Discover New Medicines
July 28, 2020
News
NEW YORK, NY - (EurekAlert) - VantAI and TARA Biosystems today announced the launch of a biology-driven, AI-enabled collaboration for accelerated cardiac drug development. The partnership will leverage TARA’s state-of-the-art in vitro human …
TARA Biosystems Report Study Results Demonstrating In Vitro Cardiac Biology Model Mimics Human Drug Response
July 28, 2020
News
NEW YORK, NY - (EurekAlert) - TARA Biosystems today reported study results demonstrating the ability of TARA’s in vitro human cardiac models to reproduce drug responses similar to those observed in humans. Appearing …
TARA Biosystems Announces $10 Million Series A2 Financing to Expand its Cardiac Disease Drug Discovery and Development Capabilities
July 28, 2020
News
NEW YORK, NY - (BUSINESS WIRE) - TARA Biosystems, Inc., a company generating in vitro human biology to increase the success of cardiac disease drug discovery and development, today announced a $10 million Series A2 …
TARA Biosystems Presents Translational Disease Models at Keystone Heart Failure Symposium
July 28, 2020
News
Heart-on-a-Chip Technology Predicts Preclinical Systolic and Diastolic in vivo Observations for Novel Cardiac Drug in Development
July 28, 2020
News
NEW YORK, NY - (Newswire.com) - TARA Biosystems, Inc. today reported in vivo and in vitro functional data from a